LQDA News and Press, Liquidia Technologies Inc. From 02/27/26

2026-02-27 07:05:53 ET In June 2025, Liquidia ( LQDA ) launched Yutrepia as a treatment for pulmonary hypertension, a relatively rare condition. The launch has gone well, and Liquidia has taken share and may continue to do so based on comments from their main competitor. This appear...

2026-02-26 11:30:08 ET Investment Overview United Therapeutics Corporation ( UTHR ), the Silver Spring, Maryland, headquartered pharma company with a multi-billion dollar pulmonary arterial hypertension ("PAH" a rare, chronic condition characterized by high blood pressure in the...

MORRISVILLE, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today that it will report its full year 2025 financial results on Thursday, March 5...

2026-02-25 13:08:10 ET More on MannKind, United Therapeutics, etc. United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call Transcript United Therapeutics Corporation 2025 Q4 - Results - Earnings Call Presentation 2026 Outlook: Afrezza, Furoscix, And MannKind's P...

MORRISVILLE, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today the company will present three posters at the Pulmonary Vascular Researc...

2026-01-23 05:00:00 ET The following segment was excerpted from the Arquitos Capital Q4 2025 Investor Letter. ... Read the full article on Seeking Alpha For further details see: Liquidia: Capturing Special Situation Gains And Longer-Term Gains

2026-01-21 14:36:34 ET More on pharmaceuticals XPH: Healthcare Dashboard For January Why PPH Keeps Working When Single Themes Break Healthcare Dashboard For December And Focus On PJP Market Voices: Trump on Venezuela, CPI data issues, drug pricing deals ...

2026-01-20 16:15:00 ET Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma companies and the pharma market as a whole. Like all ETFs, pharmaceutical ETFs are a good option for those who w...

2026-01-16 12:21:12 ET Read the full article on Seeking Alpha For further details see: XPH: Healthcare Dashboard For January

2026-01-14 22:25:59 ET Liquidia Corporation (LQDA) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 8:15 PM EST... Read the full article on Seeking Alpha For further details see: Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Confere...